FAS/FASL OR OTHER DEATH RECEPTOR TARGETED METHODS AND COMPOSITIONS FOR KILLING TUMOR CELLS

• 1. 一种响应硝基还原酶杀灭肿瘤细胞的光敏感靶向抗肿瘤前药及其制备方法与应用 [P] . 中国专利： CN107266407B . 2020.08.21
• 2. 一种响应谷胱甘肽杀灭肿瘤细胞的光敏感靶向抗肿瘤前药及其制备方法与应用 [P] . 中国专利： CN107235945B . 2019.09.03
• 3. FAS/FASL or other death receptor targeted methods and compositions for killing tumor cells [P] . AU2009303355B2 . 2015-10-01

  机译： FAS / FASL或其他靶向死亡受体的方法和组合物用于杀死肿瘤细胞

• 4. FAS/FASL OR OTHER DEATH RECEPTOR TARGETED METHODS AND COMPOSITIONS FOR KILLING TUMOR CELLS [P] . 欧洲知识产权局专利： EP2355833A4 . 2012-12-26

  机译： FAS / FASL或其他死亡受体靶向方法和杀灭肿瘤细胞的成分

• 5. Fas/FasL or other death receptor targeted methods and compositions for killing tumor cells [P] . 美国专利： US8012948B2 . 2011-09-06

  机译： Fas / FasL或其他靶向死亡受体的方法和组合物用于杀死肿瘤细胞

• 1. Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells [J] . Tanvi S Jani, Leila GobejiShvili, Prachi T Hote, 细胞研究（英文版） . 2009,第003期
• 2. Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors [J] . Min Liu, Qian Sun, Feng Wei, 癌症生物学与医学（英文版 ） . 2020,第003期
• 3. Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression. [J] . Contassot E, Kerl K, Roques S, Blood: The Journal of the American Society of Hematology . 2008,第9期
• 4. 90?Potentiation of T-cell mediated tumor killing via modulation of the fas/fasL pathway [J] . Jonathan Boiarsky, Ranjan Upadhyay, Judit Svensson-Arvelund, Journal for ImmunoTherapy of Cancer . 2020,第Suppla3期
• 5. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. [J] . Sinha P, Chornoguz O, Clements VK, Blood: The Journal of the American Society of Hematology . 2011,第20期
• 6. Anti-gastric cancer active immunity induced by FasL/B7-1 genes modified tumor cells [C] . Shi-Ying Zheng, Dong Jiang, Jun Zhao, BioMedical Information Engineering, 2009. FBIE 2009 . 2009
• 7. CD30-Redirected Chimeric Antigen Receptor T Cells Target Embryonal Carcinoma via Antigen-Dependent and Fas/FasL Interactions [D] . Hong, Lee Kyung. 2018
• 8. The Nef-Mediated AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Increased Fas/FasL Expression on T Cells and T-Cell Death but Is Not Prevented in Fas- FasL- Tumor Necrosis Factor Receptor 1- or Interleukin-1β-Converting Enzyme-Deficient or Bcl2-Expressing Transgenic Mice [O] . Elena Priceputu, Isabelle Rodrigue, Pavel Chrobak, 2005
• 9. The Nef-Mediated AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Increased Fas/FasL Expression on T Cells and T-Cell Death but Is Not Prevented in Fas-, FasL-, Tumor Necrosis Factor Receptor 1-, or Interleukin-1β-Converting Enzyme-Deficient or Bcl2-Expressing Transgenic Mice [O] . Priceputu, Elena, Rodrigue, Isabelle, Chrobak, Pavel, 2005

• 1. Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells [J] . Meng-SenLi ,Qiu-LingMa ,QianChen . 世界胃肠病学杂志：英文版 . 2005,第17期
• 2. Epidermal growth factor receptor-targeted immune magnetic liposomes capture circulating colorectal tumor cells efficiently [J] . Jing-Hua Kuai ,Qing Wang ,Ai-Jun Zhang . 世界胃肠病学杂志：英文版 . 2018,第3期
• 3. Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells [J] . Shi-YingZheng ,De-ChunLi ,Zhi-DeZhang . 世界胃肠病学杂志：英文版 . 2005,第21期
• 4. 针灸内关穴预处理对兔缺血再灌注损伤心肌细胞死亡受体通路Fas/FasL蛋白表达的影响 [C] . LIN Hai-bo ,林海波 ,YAN Jie . 全国中医药博士生学术交流会暨第四届全国中医药博士生优秀论文颁奖会议 . 2013
• 5. 骨保护素通过Fas/FasL死亡受体通路诱导破骨细胞及其前体细胞发生凋亡的研究 [A] . 刘伟 . 2016